# Is Trogocytosis a Predictive Marker of CAR-T Cell Response in Diffuse Large B-cell Lymphoma?

> **NCT06352242** · NA · RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 85 (estimated)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

- **OTHER:** Flow cytometry analysis to determine the level of trogocytosis by effector immune cells in patients
- **OTHER:** Flow cytometry analysis to determine the level of trogocytosis by effector immune cells in volunteers

## Key facts

- **NCT ID:** NCT06352242
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-22
- **Primary completion:** 2026-05-22
- **Final completion:** 2026-05-22
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06352242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06352242, "Is Trogocytosis a Predictive Marker of CAR-T Cell Response in Diffuse Large B-cell Lymphoma?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06352242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*